Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
03/2012
03/20/2012CA2405469C Integrin binding peptide derivatives
03/15/2012WO2012034025A2 Human cytomegalovirus vaccine
03/15/2012WO2012033993A2 Methods for assaying enzyme activities
03/15/2012WO2012033450A1 Novel antimicrobial peptides
03/15/2012WO2012033272A1 Human-derived cell-permeable peptide bioactive peptide conjugate, and use thereof
03/15/2012WO2012033154A1 Translation and construction of non-standard peptide compound library containing n-methyl amino acids and other non-standard amino acids, and method for searching for active species
03/15/2012WO2012033142A1 Hepatitis c virus liposome vaccine
03/15/2012WO2012032764A1 Ttll4 peptides and vaccines containing the same
03/15/2012WO2012032763A1 Vangl1 peptides and vaccines including the same
03/15/2012WO2011121289A3 Peptides and their use
03/15/2012WO2011115462A3 Seed-conjugated solid support resin, and method for removing β2-microglobulin by using same
03/15/2012US20120066792 Novel Genes Involved In Biosynthesis
03/15/2012US20120065367 Radioactively Labeled Substance
03/15/2012US20120065366 Cyclic amino acid molecules and methods of preparing the same
03/15/2012US20120065365 Stable Radiopharmaceutical Compositions and Methods for Their Preparation
03/15/2012US20120065344 Compound modified by a phosphoramidate and/or phosphonamide group and use thereof
03/15/2012US20120065149 Vitamin receptor binding drug delivery conjugates
03/15/2012US20120065147 Use of the gtpase rab27b to diagnose and treat poor prognosis estrogen-receptor-positive breast cancer
03/15/2012US20120065146 Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
03/15/2012US20120065142 Novel solid materials of and methods for obtaining them
03/15/2012US20120065139 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof
03/15/2012US20120065124 Cell-penetrating peptides
03/15/2012US20120065103 Prolyl Endopeptidase Probes
03/15/2012US20120064554 Methods for assaying enzyme activities
03/15/2012US20120064102 Peptide inducing xage-1b-specific immune reaction and utilization of same
03/15/2012US20120064034 Peptidomimetic protease inhibitors
03/15/2012US20120063993 Therapeutic and diagnostic conjugates for use with multispecific antibodies
03/15/2012CA2810636A1 Ttll4 peptides and vaccines containing the same
03/14/2012EP2428222A2 Vaccine peptide combinations against cat allergy
03/14/2012EP2427492A1 Biomarker antibody and diagnosis device for detecting certain autoimmune diseases
03/14/2012EP2427477A1 Method for the preparation of cyclopeptides
03/14/2012EP2427476A1 Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
03/14/2012EP2427475A1 High penetration prodrug compositions of peptides and peptide-related compounds
03/14/2012EP2427210A1 Modulation of inducible nitric oxide (inos) binding to spry domain-containing socs-box peptides (ssb)
03/14/2012EP1910837B1 Methods and compositions for diagnosis and treatment of influenza
03/14/2012CN1804628B Peptide for distinguishing prion
03/14/2012CN102372766A O-type foot-and-mouth disease multi-epitope vaccine with cross immunity protective efficiency
03/14/2012CN102372764A Novel peptides as NS3-serine protease inhibitors of hepatitis c virus
03/14/2012CN101565455B CTL epitope polypeptides of bird flu H5N1 virus and applications thereof
03/13/2012US8133709 Target sequences for synthetic molecules
03/13/2012US8133471 CLK-peptide and SLK-peptide
03/13/2012CA2489227C Hla-a24-restricted cancer antigen peptides
03/13/2012CA2419607C Peptidomimetic protease inhibitors
03/13/2012CA2365898C Ibd-associated microbial antigens and methods of using same
03/13/2012CA2347649C Mn gene and protein
03/13/2012CA2195955C Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/08/2012WO2012031250A2 Compositions for labeling nerves and methods of use
03/08/2012WO2012031228A2 Llp2a-bisphosphonate conjugates for osteoporosis treatment
03/08/2012WO2012031103A2 Inhibitors of bcl-2
03/08/2012WO2012029415A1 Blood insulin resistance and diabetes marker progranulin, method for analyzing concentration of progranulin in blood sample, and method for screening for substance that improves insulin resistance and improves or suppresses diabetes
03/08/2012WO2012027850A1 Peptide containing multiple n-linked glycosylation sequons
03/08/2012WO2012004678A3 Serine protease inhibitors
03/08/2012WO2003032894A3 Method of monitoring neuroprotective treatment
03/08/2012US20120060231 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
03/08/2012US20120060230 Methods and compositions for modification of a hla locus
03/08/2012US20120059148 Non-naturally occurring lipoprotein particle
03/08/2012US20120059146 Method for the preparation of cyclopeptides
03/08/2012US20120059145 Stabilized bioactive peptides and methods of identification, synthesis, and use
03/08/2012US20120058958 Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
03/08/2012US20120058957 Compositions and methods for counteracting effects of reactive oxygen species and free radicals
03/08/2012US20120058953 Compositions and methods for enhancing apoptosis
03/08/2012US20120058952 Hmg-coa reductase derived peptide and cosmetic or pharmaceutical composition containing same
03/08/2012US20120058946 Compound and method for treating myotonic dystrophy
03/08/2012US20120058945 Neuroprotective iron chelators and pharmaceutical compositions comprising them
03/08/2012US20120058933 Synthetic peptides and peptide mimetics
03/08/2012US20120058932 Active ingredient-peptide construct for extracellular concentration
03/08/2012US20120058495 Recombinant fragments and synthetic peptides of 17-kDa polypeptide useful in detecting Bartonella henselae
03/08/2012US20120058487 Compositions and methods for detecting klebsiella pneumoniae
03/08/2012US20120058202 Means and Method for Ovarian Cancer Prognosis
03/08/2012US20120058143 Staphylococcus aureus proteins and nucleic acids
03/08/2012US20120058135 Identification and characterization of racemases, definition of protein signatures, and a test for detecting D-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/08/2012US20120058127 PAR2 Agonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
03/08/2012US20120058120 Targets for Growth Factor Signalling and Methods of Therapy
03/08/2012US20120058066 Self-assembling peptide and peptide gel with high strength
03/08/2012US20120055781 Microwave-assisted peptide synthesis
03/08/2012CA2809890A1 Peptide containing multiple n-linked glycosylation sequons
03/07/2012EP2426139A1 CXCR4 antagonist and use thereof
03/07/2012EP2424879A1 Influenza vaccine
03/07/2012EP2424557A1 Modified compstatin with peptide backbone and c-terminal modifications
03/07/2012EP1727904B1 Peptide-based method for monitoring gene expression in a host cell
03/07/2012EP1355923B1 Immunomodulatory peptides derived from heat shock proteins and uses thereof
03/07/2012CN102369281A HLA-A24-binding cancer antigen peptide derived from SOX2
03/07/2012CN102369242A Polyion complex comprising hydrophobized polyamino acid and use of same
03/07/2012CN102369210A Antibiotic peptides
03/07/2012CN102367270A Preparation method of cyclosporin A haptin and enzymelinked immunosorbent quantitative detection kit of cyclosporin A
03/07/2012CN102367269A Caspofungin analogue, its preparation method and application
03/07/2012CN102367268A Caspofungin analogue and use thereof
03/07/2012CN102367267A Preparation method of caspofungin
03/07/2012CN102367266A Oligopeptide B and its antibacterial application
03/07/2012CN102367265A Oligopeptide D and antimicrobial application thereof
03/07/2012CN101397332B Functional peptide section of epididymis protease inhibitors and multiple antigenic peptide constructed thereby
03/06/2012US8129407 Hemiasterlin derivatives and uses thereof in the treatment of cancer
03/06/2012US8129342 High purity lipopeptides
03/06/2012US8129332 Reagents and methods for smooth muscle therapies
03/06/2012US8129331 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT
03/06/2012CA2202408C Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
03/01/2012WO2012027365A2 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/01/2012WO2012026526A1 Hemokinin-1 receptor and hemokinin-1-derived peptide
03/01/2012WO2012026309A1 Creation of anti-pad4 antibody pharmaceutical
03/01/2012WO2012025651A1 Biomaterial comprising osteostatin for osseous regeneration and tissue engineering
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 423